OSF Healthcare and Wanxiang both returned for the extension having also contributed to a $45m first close for the patient management platform developer.
US-based patient management technology developer Endotronix yesterday increased its series D round from $45m to $70m following an extension backed by healthcare provider OSF Healthcare and automotive component producer Wanxiang.
Aperture Venture Partners, BioVentures Investors, Lumira Ventures, Seroba Life Sciences, Skydeck, SV Health Investors, an undisclosed investor in the medical devices sector and an unnamed corporate backer also took part in the extension.
LSP had led the initial close in September 2018 through its LSP Health Economics Fund 2…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
